Skip to Main Content

Paper Details

Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.
Am J Transplant
10
2021
DAA, HCV, HIV, advanced liver, decompensated liver disease, end-stage liver disease, hepatitis C (, hepatocellular carcinoma, human immunodeficiency virus, participants, patients, sofosbuvir
Author NameAffiliation
Mark S SulkowskiJohns Hopkins University
Thomas M FishbeinMedstar Georgetown Transplant Institute, Georgetown University
  • 1 - 2

Datasets

Release 1.2